← Back to Clinical Trials
Recruiting NCT07512141

NCT07512141 Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07512141
Status Recruiting
Phase
Sponsor Sindh Institute of Urology and Transplantation
Condition Seroma Following Procedure
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-27
Primary Completion 2027-03-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
Double drains will be placedA single drain will be placed

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-03-27 with a primary completion date of 2027-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Normally, after this surgery, skin is stitched in the usual simple way, with no quilting, and two drains are put in to remove serosa, one under the arm and one on the chest. In this study, the investigator will use a different type of stitch called a quilting stitch, which helps stick the skin to the chest muscle so there is less serosa collection. The investigator will compare two groups: * Group A: Quilting stitches with two drains (one under the arm and one on the chest). * Group B: Quilting stitches with one drain only (under the arm).

Eligibility Criteria

Inclusion Criteria: * All patients older than 18 years but less than 70 years of age, * Diagnosed with breast carcinoma. * All the patients undergoing upfront MRM, * All patients undergoing MRM post-neoadjuvant chemotherapy. Exclusion Criteria: * Mastectomy \& sentinel lymph node biopsy * Breast reconstruction surgery * Defect covering flaps

Contact & Investigator

Central Contact

Syed Abbas, FCPS

✉ smabbas69@hotmail.com

📞 +923331318838

Principal Investigator

Bushra Shirazi, FCPS

PRINCIPAL INVESTIGATOR

Sindh Institute of Urology and Transplantation

Frequently Asked Questions

Who can join the NCT07512141 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 70 Years, studying Seroma Following Procedure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07512141 currently recruiting?

Yes, NCT07512141 is actively recruiting participants. Contact the research team at smabbas69@hotmail.com for enrollment information.

Where is the NCT07512141 trial being conducted?

This trial is being conducted at Karachi, Pakistan.

Who is sponsoring the NCT07512141 clinical trial?

NCT07512141 is sponsored by Sindh Institute of Urology and Transplantation. The principal investigator is Bushra Shirazi, FCPS at Sindh Institute of Urology and Transplantation. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology